These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10364178)

  • 1. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
    Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
    J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
    Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
    J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
    Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
    J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
    Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
    Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
    Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
    FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
    Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
    Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage inflammatory protein-1.
    Menten P; Wuyts A; Van Damme J
    Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5.
    Nibbs RJ; Wylie SM; Pragnell IB; Graham GJ
    J Biol Chem; 1997 May; 272(19):12495-504. PubMed ID: 9139699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
    Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
    J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB; Glushakova S; Grivel JC; Murphy PM
    J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
    Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
    J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MIP-1alpha and anti-RANTES antibodies: new allies of HIV-1?
    Kissler S; Süsal C; Opelz G
    Clin Immunol Immunopathol; 1997 Sep; 84(3):338-41. PubMed ID: 9281393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
    Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
    Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.